Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is NuVasive, Inc. (NUVA) a Good Stock To Buy?

Page 1 of 2

Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don’t publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That’s why we analyze the activity of those elite funds in these small-cap stocks. In the following paragraphs, we will analyze NuVasive, Inc. (NASDAQ:NUVA) from the perspective of those elite funds.

So, is NuVasive, Inc. (NASDAQ:NUVA) a bargain? The smart money seems to be taking a bearish view, since the number of bullish hedge fund positions was trimmed by two in recent months. However, the level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Two Harbors Investment Corp (NYSE:TWO), Black Stone Minerals LP (NYSE:BSM), and Integra Lifesciences Holdings Corp (NASDAQ:IART) to gather more data points.

Follow Nuvasive Inc (NASDAQ:NUVA)
Trade (NASDAQ:NUVA) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

medical, operation, surgeon, equipment, doctor, team, face, monitor, training, woman, technician, male, specialist, mask, uniform, man, teamwork, competence, partners,

Kotin/Shutterstock.com

With all of this in mind, let’s take a look at the fresh action encompassing NuVasive, Inc. (NASDAQ:NUVA).

How are hedge funds trading NuVasive, Inc. (NASDAQ:NUVA)?

At Q3’s end, 27 funds tracked by Insider Monkey held long positions in this stock, down by 7% over the quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their stakes substantially (or already accumulated large positions).

HedgeFundSentimentChart

According to Insider Monkey’s hedge fund database, Ken Fisher’s Fisher Asset Management has the largest position in NuVasive, Inc. (NASDAQ:NUVA), worth close to $94.8 million, accounting for 0.2% of its total 13F portfolio. The second most bullish fund manager is Columbus Circle Investors, managed by Principal Global Investors, which holds a $49.1 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Remaining members of the smart money with similar optimism contain Anand Parekh’s Alyeska Investment Group, Ken Griffin’s Citadel Investment Group, and Nick Niell’s Arrowgrass Capital Partners.

Page 1 of 2
Loading Comments...